Company

miReven Pty Ltd

Pharmaceutical Manufacturing Au 3 employees

Employees: 3
Contacts: 1
Emails: 1

mireven.com.au LinkedIn

miReven Pty Ltd Overview

Headquarters: Au
Phone Number: Available in AeroLeads
Website: mireven.com.au
Industry: Pharmaceutical Manufacturing
Employees: 3
Founded: 2010
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

Scarborough

About miReven Pty Ltd

miR-7: An anti-cancer micro RNA miReven is a biopharmaceutical company focused on developing miR-7 as a cancer therapy. The Company was formed in 2010 through an investment from the Medical Research Commercialisation Fund (MRCF). The Company’s published research shows that miR-7 can knock-out an essential growth receptor for cancer, known as the epidermal growth factor receptor (EGFR), as well as its associated signaling pathways that promote cancer development. EGFR is a major target for cancer therapy because it is often associated with disease progression, resistance to chemotherapy and radiation therapy. WAIMR is assisted in the commercialisation of its intellectual property by the University of Western Australia, through its Office of Industry and Innovation.

miReven Pty Ltd Contact Details

People in AeroLeads: 2
With contact data: 1
Email contacts: 1; 50.0% coverage

miReven Pty Ltd Org Chart

Sample employees and titles

Name	Title	Location	Contact
Felicity Kalinowski	Senior Research Officer at Harry	Greater Perth Area, Australia	View
Peter Leedman	Director, Harry Perkins Institute	Greater Perth Area, Australia	Email